Health Products

Dimension Hemoglobin A1C (HB1C) Assay

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesModel or catalog number
More than 10 numbers, contact manufacturerA. Dimension Hemoglobin A1C (HB1C) Assay
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC Drive, Mailstop 514, PO Box 6101
Newark
19714-6101
Delaware
UNITED STATES
DF105A

Introduction

Recalled Products
  1. Dimension Hemoglobin A1C (HB1C) Assay

Reason

Customers have been experiencing a higher frequency of "above assay range" flags on patient samples with the Dimension HB1C method. Upon dilution, the result is usually well within the range of the assay. Some customers understand the issue is hemoglobin being above the assay range of > 25 g/dl and have verified on an independent system that hemoglobin on affected samples are < 25 g/dl.  Some customers have experienced a high bias on US cap survey samples (2012 GH2-B) with the HB1C method. Cap samples that failed are in the normal range of the method.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime